Association between BMI and colorectal cancer risk
the ONA take:
High pre-diagnosis body mass index (BMI) was associated with increased mortality among patients with colorectal cancer, a new study published in the journal Cancer Epidemiology, Biomarkers & Prevention has shown.
For the study, researchers sought to evaluate the association between BMI and colorectal cancer survival. Researchers analyzed data from 5,615 men and women diagnosed with invasive colorectal cancer who were followed for an average of 5.9 years.
Results showed that high pre-diagnosis BMI was associated with a higher risk of all-cause mortality. The risk of death did not significantly vary by sex, location of cancer, or BRAF mutation status.
According to the National Cancer Institute, previous research has demonstrated that a higher BMI is strongly associated with an increased risk for colorectal cancer among men. A strong association between BMI and waist circumference with colon cancer has been observed in men, with a weaker association observed in women.
High pre-diagnosis body mass index (BMI) was associated with increased mortality among patients with colorectal cancer.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|